SONN insider transactions
Sonnet BioTherapeutics Holdings Inc. (SONN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for SONN
- Chief Medical Officer Kenney Richard T returned 242,748 shares to the company, converted options into 250,265 shares and covered exercise/tax liability with 16,891 shares, closing all direct ownership in the company (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chief Business Officer Mcandrew Stephen J returned 6,446 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Dexter Susan returned 9,643 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Dyrness Albert D. returned 4,537 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Bhatt Nailesh returned 10,547 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Cini John K. returned 14,116 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chief Executive Officer Rao Raghu returned 22,356 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chief Financial Officer Griffith Donald J. returned 10,375 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Mcneill Lori returned 4,394 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4 filed by Chief Medical Officer Kenney Richard T4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chief Medical Officer Kenney Richard T was granted 8,000 shares, increasing direct ownership by 582% to 9,374 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Bhatt Nailesh was granted 10,000 shares, increasing direct ownership by 1,828% to 10,547 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chief Financial Officer Griffith Donald J. was granted 10,000 shares, increasing direct ownership by 2,667% to 10,375 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chief Business Officer Mcandrew Stephen J was granted 6,000 shares, increasing direct ownership by 1,345% to 6,446 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Dyrness Albert D. was granted 4,000 shares, increasing direct ownership by 745% to 4,537 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Interim CEO Rao Raghu was granted 20,000 shares, increasing direct ownership by 849% to 22,356 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Mcneill Lori was granted 4,000 shares, increasing direct ownership by 1,015% to 4,394 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chief Scientific Officer Cini John K. was granted 12,000 shares, increasing direct ownership by 567% to 14,116 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chief Technical Officer Dexter Susan was granted 8,000 shares, increasing direct ownership by 487% to 9,643 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- New insider Mcandrew Stephen J claimed ownership of 446 shares (SEC Form 3)3 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Bhatt Nailesh was granted 373 shares, increasing direct ownership by 214% to 547 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chief Technical Officer Dexter Susan was granted 1,452 shares, increasing direct ownership by 760% to 1,643 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chairman, President and CEO Mohan Pankaj was granted 7,554 shares, increasing direct ownership by 102% to 14,987 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Dyrness Albert D. was granted 373 shares, increasing direct ownership by 227% to 537 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Mcneill Lori was granted 373 shares, increasing direct ownership by 1,776% to 394 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chief Scientific Officer Cini John K. was granted 1,888 shares, increasing direct ownership by 828% to 2,116 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Rao Raghu was granted 373 shares, increasing direct ownership by 19% to 2,356 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chief Medical Officer Kenney Richard T was granted 1,271 shares, increasing direct ownership by 1,234% to 1,374 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Chief Financial Officer Cross John Harry Iii gave a grant of 1,452 shares, decreasing direct ownership by 48% to 1,588 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Director Griffith Donald J. was granted 317 shares, increasing direct ownership by 547% to 375 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Mohan Pankaj bought 34,375 shares, increasing direct ownership by 137% to 59,526 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- Rao Raghu bought 15,625 shares, increasing direct ownership by 1,315% to 16,813 units (SEC Form 4)4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 3: New insider Markey John claimed ownership of 186,430 shares3 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4 filed by Dexter Susan4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4 filed by Dyrness Albert D.4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4 filed by Bhatt Nailesh4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4 filed by Mohan Pankaj4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Mohan Pankaj bought $35,100 worth of shares (60,000 units at $0.58), increasing direct ownership by 49% to 181,731 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Mohan Pankaj returned 73,561 shares to the company and was granted 73,561 shares4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Dexter Susan was granted 14,627 shares and returned 14,627 shares to the company4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Kenney Richard T returned 14,627 shares to the company and was granted 14,627 shares4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Cini John K. returned 18,551 shares to the company and was granted 18,551 shares4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Cross John Harry Iii covered exercise/tax liability with 1,960 shares, decreasing direct ownership by 8% to 23,927 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Griffith Donald J. was granted 3,214 shares and covered exercise/tax liability with 497 shares, increasing direct ownership by 36% to 10,301 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Rao Raghu was granted 3,770 shares, increasing direct ownership by 17% to 26,140 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Mohan Pankaj was granted 74,205 shares, increasing direct ownership by 11% to 748,606 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Dexter Susan was granted 14,627 shares, increasing direct ownership by 12% to 141,199 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Kenney Richard T was granted 14,627 shares, increasing direct ownership by 29% to 64,627 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Mcneill Lori was granted 3,770 shares4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Cross John Harry Iii was granted 15,519 shares, increasing direct ownership by 11% to 160,684 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Dyrness Albert D. was granted 3,770 shares, increasing direct ownership by 14% to 30,893 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Bhatt Nailesh was granted 3,770 shares, increasing direct ownership by 14% to 31,255 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Cini John K. was granted 18,551 shares, increasing direct ownership by 6% to 322,652 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 3 filed by new insider Mcneill Lori3 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Griffith Donald J. was granted 15,000 shares and covered exercise/tax liability with 4,507 shares, increasing direct ownership by 11% to 106,186 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Bhatt Nailesh was granted 14,152 shares, increasing direct ownership by 106% to 27,485 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Mohan Pankaj was granted 320,135 shares, increasing direct ownership by 90% to 674,401 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Dexter Susan was granted 63,104 shares, increasing direct ownership by 99% to 126,572 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Cini John K. was granted 80,034 shares, increasing direct ownership by 36% to 304,101 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)
- SEC Form 4: Rao Raghu was granted 14,152 shares, increasing direct ownership by 172% to 22,370 units4 - Sonnet BioTherapeutics Holdings, Inc. (0001106838) (Issuer)